Medtronic (MDT) Short term Debt (2014 - 2026)

Medtronic's Short term Debt history runs 13 years deep, the most recent figure standing at $191.0 million for Q1 2026.

• In Q1 2026, Short term Debt fell 92.72% year-over-year to $191.0 million; the TTM figure through Jan 2026 stood at $191.0 million (down 92.72% YoY), while the FY2025 annual figure was $2.9 billion, up 163.19% from the prior year.
• Short term Debt came in at $191.0 million for Q1 2026 at Medtronic, down from $1.4 billion in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $5.9 billion in Q1 2023 to a low of $20.0 million in Q2 2023.
• A 5-year average of $2.4 billion and a median of $1.6 billion in 2024 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt surged 95383.33% in 2022 and slumped 99.47% in 2023, its largest moves.
• Medtronic's Short term Debt stood at $5.9 billion in 2022, then slumped by 77.17% to $1.3 billion in 2023, then soared by 177.74% to $3.7 billion in 2024, then sank by 61.82% to $1.4 billion in 2025, then slumped by 86.55% to $191.0 million in 2026.
• According to Business Quant data, Short term Debt over the past three periods registered $191.0 million, $1.4 billion, and $2.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison